147 related articles for article (PubMed ID: 12639061)
1. Responsiveness of the quality of life in epilepsy inventory (QOLIE-89) in an antiepileptic drug trial.
Kim S; Hays RD; Birbeck GL; Vickrey BG
Qual Life Res; 2003 Mar; 12(2):147-55. PubMed ID: 12639061
[TBL] [Abstract][Full Text] [Related]
2. Quality of life measures in epilepsy: how well can they detect change over time?
Birbeck GL; Kim S; Hays RD; Vickrey BG
Neurology; 2000 May; 54(9):1822-7. PubMed ID: 10802791
[TBL] [Abstract][Full Text] [Related]
3. Seizure reduction and quality of life improvements in people with epilepsy.
Birbeck GL; Hays RD; Cui X; Vickrey BG
Epilepsia; 2002 May; 43(5):535-8. PubMed ID: 12027916
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and responsiveness of the EQ-5D-3L in patients with uncontrolled focal seizures: an analysis of Phase III trials of adjunctive brivaracetam.
Mukuria C; Young T; Keetharuth A; Borghs S; Brazier J
Qual Life Res; 2017 Mar; 26(3):749-759. PubMed ID: 28004320
[TBL] [Abstract][Full Text] [Related]
5. Psychometric validation of the French version of the quality of life in epilepsy inventory (QOLIE-31): comparison with a generic health-related quality of life questionnaire.
Picot MC; Crespel A; Daurès JP; Baldy-Moulinier M; El Hasnaoui A
Epileptic Disord; 2004 Dec; 6(4):275-85. PubMed ID: 15634625
[TBL] [Abstract][Full Text] [Related]
6. Development of the Quality of Life in Epilepsy Inventory for Adolescents: the QOLIE-AD-48.
Cramer JA; Westbrook LE; Devinsky O; Perrine K; Glassman MB; Camfield C
Epilepsia; 1999 Aug; 40(8):1114-21. PubMed ID: 10448825
[TBL] [Abstract][Full Text] [Related]
7. Reliability and validity of QOLIE-10 in measuring health-related quality of life (HRQoL) in Chinese epilepsy patients.
Gao L; Xia L; Pan SQ; Xiong T; Li SC
Epilepsy Res; 2014 Mar; 108(3):565-75. PubMed ID: 24534759
[TBL] [Abstract][Full Text] [Related]
8. [Validation of the Spanish version of the QOLIE-10 quality of life in epilepsy questionnaire].
Viteri C; Codina M; Cobaleda S; Lahuerta J; Barriga J; Barrera S; Morales MD;
Neurologia; 2008 Apr; 23(3):157-67. PubMed ID: 18370335
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in psychogenic nonepileptic seizures.
Szaflarski JP; Hughes C; Szaflarski M; Ficker DM; Cahill WT; Li M; Privitera MD
Epilepsia; 2003 Feb; 44(2):236-42. PubMed ID: 12558580
[TBL] [Abstract][Full Text] [Related]
10. Reliability and validity of a Chinese version of the Quality of Life in Epilepsy Inventory (QOLIE-89).
Zhao Y; Ding C; Wang Y; Li Z; Zhou Y; Huang Y
Epilepsy Behav; 2007 Aug; 11(1):53-9. PubMed ID: 17499025
[TBL] [Abstract][Full Text] [Related]
11. Changes in quality of life in epilepsy: how large must they be to be real?
Wiebe S; Eliasziw M; Matijevic S
Epilepsia; 2001 Jan; 42(1):113-8. PubMed ID: 11207794
[TBL] [Abstract][Full Text] [Related]
12. Assessing responsiveness of generic and specific health related quality of life measures in heart failure.
Eurich DT; Johnson JA; Reid KJ; Spertus JA
Health Qual Life Outcomes; 2006 Nov; 4():89. PubMed ID: 17125512
[TBL] [Abstract][Full Text] [Related]
13. The Spanish Version of the Quality-of-Life in Epilepsy Inventory (QOLIE-31): translation, validity, and reliability.
Torres X; Arroyo S; Araya S; de Pablo J
Epilepsia; 1999 Sep; 40(9):1299-304. PubMed ID: 10487195
[TBL] [Abstract][Full Text] [Related]
14. Epilepsy in patients with primary brain tumors: The impact on mood, cognition, and HRQOL.
Rahman Z; Wong CH; Dexter M; Olsson G; Wong M; Gebsky V; Nahar N; Wood A; Byth K; King M; Bleasel AB
Epilepsy Behav; 2015 Jul; 48():88-95. PubMed ID: 26136184
[TBL] [Abstract][Full Text] [Related]
15. Evaluating health-related quality of life outcomes in clinical trials of antiepileptic drug therapy.
Kline Leidy N; Rentz AM; Grace EM
Epilepsia; 1998 Sep; 39(9):965-77. PubMed ID: 9738676
[TBL] [Abstract][Full Text] [Related]
16. Psychometric properties of the Bulgarian version of the Quality of Life in Epilepsy Inventory (QOLIE-31).
Todorova KS; Velikova VS; Tsekov ST
Epilepsy Behav; 2013 Aug; 28(2):203-10. PubMed ID: 23770634
[TBL] [Abstract][Full Text] [Related]
17. Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments.
Luoni C; Bisulli F; Canevini MP; De Sarro G; Fattore C; Galimberti CA; Gatti G; La Neve A; Muscas G; Specchio LM; Striano S; Perucca E;
Epilepsia; 2011 Dec; 52(12):2181-91. PubMed ID: 22136077
[TBL] [Abstract][Full Text] [Related]
18. [Age aspects of quality of life research in patients with epilepsy].
Melikian EG; Mil'chakova LE; Lebedeva AV; Bondareva IB; Gekht AB
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6 Pt 2):78-82. PubMed ID: 22983253
[TBL] [Abstract][Full Text] [Related]
19. Comparison between the QOLIE-31 and derived QOLIE-10 in a clinical trial of levetiracetam.
Cramer JA; Arrigo C; Van Hammée G; Bromfield EB
Epilepsy Res; 2000 Aug; 41(1):29-38. PubMed ID: 10924866
[TBL] [Abstract][Full Text] [Related]
20. Advances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life.
Wagner AK; Keller SD; Kosinski M; Baker GA; Jacoby A; Hsu MA; Chadwick DW; Ware JE
Qual Life Res; 1995 Apr; 4(2):115-34. PubMed ID: 7780379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
